Your browser doesn't support javascript.
loading
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
Fabritz, Larissa; Crijns, Harry J G M; Guasch, Eduard; Goette, Andreas; Häusler, Karl Georg; Kotecha, Dipak; Lewalter, Thorsten; Meyer, Christian; Potpara, Tatjana S; Rienstra, Michiel; Schnabel, Renate B; Willems, Stephan; Breithardt, Guenter; Camm, A John; Chan, Anthony; Chua, Winnie; de Melis, Mirko; Dimopoulou, Christina; Dobrev, Dobromir; Easter, Christina; Eckardt, Lars; Haase, Doreen; Hatem, Stephane; Healey, Jeff S; Heijman, Jordi; Hohnloser, Stefan H; Huebner, Thomas; Ilyas, Bushra Saeed; Isaacs, Aaron; Kutschka, Ingo; Leclercq, Christophe; Lip, Gregory Y H; Marinelli, Elena Andreassi; Merino, Jose L; Mont, Lluís; Nabauer, Michael; Oldgren, Jonas; Pürerfellner, Helmut; Ravens, Ursula; Savelieva, Irina; Sinner, Moritz F; Sitch, Alice; Smolnik, Rüdiger; Steffel, Jan; Stein, Kenneth; Stoll, Monika; Svennberg, Emma; Thomas, Dierk; Van Gelder, Isabelle C; Vardar, Burcu.
Affiliation
  • Fabritz L; Institute of Cardiovascular Sciences, University of Birmingham, UK.
  • Crijns HJGM; Department of Cardiology, University Hospital Birmingham, UK.
  • Guasch E; School for Cardiovascular Diseases, Maastricht University Medical Centre, the Netherlands.
  • Goette A; Hospital Clinic, IDIBAPS, CIBERCV, University of Barcelona, Spain.
  • Häusler KG; Medical Clinic II, St. Vincenz Krankenhaus, Paderborn, Germany.
  • Kotecha D; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Lewalter T; Department of Neurology, University Hospital Würzburg, Germany.
  • Meyer C; Institute of Cardiovascular Sciences, University of Birmingham, UK.
  • Potpara TS; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Rienstra M; Internistisches Klinikum München Süd, Germany.
  • Schnabel RB; University Heart Center, University Hospital Hamburg-Eppendorf, Germany.
  • Willems S; School of Medicine, University of Belgrade, Clinical Centre of Serbia, Serbia.
  • Breithardt G; University Medical Center Groningen, the Netherlands.
  • Camm AJ; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Chan A; University Heart Center, University Hospital Hamburg-Eppendorf, Germany.
  • Chua W; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • de Melis M; Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
  • Dimopoulou C; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Dobrev D; Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.
  • Easter C; Department of Cardiovascular Medicine, University Hospital Münster, Germany.
  • Eckardt L; St George's Hospital Medical School, University of London, UK.
  • Haase D; Pfizer.
  • Hatem S; Institute of Cardiovascular Sciences, University of Birmingham, UK.
  • Healey JS; Medtronic.
  • Heijman J; European Society of Cardiology.
  • Hohnloser SH; Department of Cardiology, University Hospital Essen, Germany.
  • Huebner T; Institute of Cardiovascular Sciences, University of Birmingham, UK.
  • Ilyas BS; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Isaacs A; Department of Cardiovascular Medicine, University Hospital Münster, Germany.
  • Kutschka I; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Leclercq C; Department of Cardiology, Sorbonne Universités, Faculté de médecine UPMC, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
  • Lip GYH; Population Health Research Institute Hamilton, Canada.
  • Marinelli EA; Department of Cardiology, University Hospital Birmingham, UK.
  • Merino JL; Department of Cardiology, Goethe-University of Frankfurt, Germany.
  • Mont L; Preventicus, Germany.
  • Nabauer M; Pfizer.
  • Oldgren J; School for Cardiovascular Diseases, Maastricht University Medical Centre, the Netherlands.
  • Pürerfellner H; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Ravens U; Klinik für Thorax-, Herz- und Gefäßchirurgie, University Hospital Göttingen, Germany.
  • Savelieva I; Univ Rennes, CHU Rennes, INSERM, LTSI-UMR 1099, F-35000 Rennes, France.
  • Sinner MF; Liverpool Centre for Cardiovascular Science, University of Liverpool, UK.
  • Sitch A; Daiichi Sankyo Europe.
  • Smolnik R; Arrhythmia & Robotic EP Unit, La Paz University Hospital, Spain.
  • Steffel J; Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Stein K; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Stoll M; Medizinische Klinik und Poliklinik I, University Hospital Munich, Germany.
  • Svennberg E; Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Sweden.
  • Thomas D; Department für Rhythmologie und Elektrophysiologie, Ordensklinikum Linz, Austria.
  • Van Gelder IC; Atrial Fibrillation NETwork (AFNET), Münster, Germany.
  • Vardar B; Institut für Experimentelle Kardiovaskuläre Medizin, Universitätsherzzentrum Freiburg, Bad Krozingen, Germany.
Europace ; 23(3): 329-344, 2021 03 08.
Article in En | MEDLINE | ID: mdl-33555020
ABSTRACT

AIMS:

The risk of developing atrial fibrillation (AF) and its complications continues to increase, despite good progress in preventing AF-related strokes. METHODS AND

RESULTS:

This article summarizes the outcomes of the 7th Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) held in Lisbon in March 2019. Sixty-five international AF specialists met to present new data and find consensus on pressing issues in AF prevention, management and future research to improve care for patients with AF and prevent AF-related complications. This article is the main outcome of an interactive, iterative discussion between breakout specialist groups and the meeting plenary. AF patients have dynamic risk profiles requiring repeated assessment and risk-based therapy stratification to optimize quality of care. Interrogation of deeply phenotyped datasets with outcomes will lead to a better understanding of the cardiac and systemic effects of AF, interacting with comorbidities and predisposing factors, enabling stratified therapy. New proposals include an algorithm for the acute management of patients with AF and heart failure, a call for a refined, data-driven assessment of stroke risk, suggestions for anticoagulation use in special populations, and a call for rhythm control therapy selection based on risk of AF recurrence.

CONCLUSION:

The remaining morbidity and mortality in patients with AF needs better characterization. Likely drivers of the remaining AF-related problems are AF burden, potentially treatable by rhythm control therapy, and concomitant conditions, potentially treatable by treating these conditions. Identifying the drivers of AF-related complications holds promise for stratified therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Europace Journal subject: CARDIOLOGIA / FISIOLOGIA Year: 2021 Document type: Article Affiliation country: United kingdom
...